Topical versus subconjunctival anti-vascular endothelial growth factor therapy (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularization. [electronic resource]
Publication details: Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society Description: 99-105 p. digitalISSN:- 1319-4534
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.